Full-Time

Clinical Specialist

Cas

Updated on 3/14/2025

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Compensation Overview

$76k - $85kAnnually

+ Sales Incentive Plan

Mid, Senior

Salt Lake City, UT, USA + 4 more

More locations: Las Vegas, NV, USA | Boise, ID, USA | Denver, CO, USA | Bozeman, MT, USA

Candidates must be based within their assigned territory each day and may be required to travel outside of their assigned territory occasionally.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • High School diploma PLUS a minimum 6 years of work experience in healthcare within an EP, Cath Lab setting or sales in cardiac field​
  • OR Associate degree PLUS a minimum of 4 years of work experience in healthcare within an EP, Cath Lab setting or sales in cardiac field
  • OR Bachelor degree PLUS a minimum 2 years work experience in healthcare within an EP, Cath Lab setting or sales in cardiac field
Responsibilities
  • Provide technical, educational, clinical and sales support to assist the Region in meeting Cardiac Ablation Solutions sales and customer service objectives.
  • Represents Medtronic CAS during ablations procedures to provide troubleshooting and other technical assistance
  • Receives technical inquiries by customers. Researches solutions to questions or problems (e.g., Catheter, Console, Generator support)
  • Educates and trains physicians, hospital personnel and office staff on technical matters relating to AFS products and related procedures.
  • Assists RM and field training department in educating/training new Clinical Specialists and Account Managers.
  • Updates sales representatives concerning procedure. Immediately notifies Account Manager regarding issues or problems requiring follow-up.
Desired Qualifications
  • Preference will be given to local qualified candidates and candidates with Medtronic experience
  • B.A./B.S. Degree in nursing, cardiovascular, life sciences, or technical discipline with minimum of four years’ work experience in cardiac field, hospital/clinic or sales
  • Pacing school/ATI-like training program in addition to BQs
  • Proven track record with technical training assignments
  • Experience in the cardiac catheter ablation field, EP lab, in a hospital/clinic or EP medical sales providing technical / clinical support

Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, such as pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals, clinics, and healthcare professionals around the world. Medtronic stands out from competitors by not only focusing on product development but also offering comprehensive services, including training for healthcare providers and patient management programs. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through its advanced medical solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Medtronic's Evolut TAVR system shows superior performance in recent clinical trials.
  • Named one of the 2025 World's Most Ethical Companies, enhancing brand reputation.
  • Launch of a 10-year initiative to train 1M students in health tech careers.

What critics are saying

  • Loss of key financial leadership may impact strategic decisions and investor confidence.
  • Increased competition in the TAVR market could affect Medtronic's market share.
  • Challenges in maintaining dividend growth amidst economic uncertainties.

What makes Medtronic unique

  • Medtronic leads in cardiovascular, diabetes, neurological, and surgical technologies globally.
  • The company invests heavily in R&D for innovative medical devices and therapies.
  • Medtronic offers comprehensive services, including training and patient management, enhancing product value.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Business Wire
Mar 11th, 2025
nVent Announces New Executive Leadership Appointments

Gary joins nVent from Medtronic, where he serves as Senior Vice President, Corporate Finance after serving as Interim Chief Financial Officer from August 2024 to March 2025.

Charities.org
Mar 11th, 2025
Sustainability News provided by 3BL

Medtronic named one of the 2025 World's Most Ethical Companies for the third time by Ethisphere.

Medical Device Network
Mar 10th, 2025
Medtronic announces two-year trial outcomes of Evolut TAVR

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial's two-year outcomes of the Evolut transfemoral transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) and small aortic annulus.

DiCardiology
Mar 10th, 2025
Medtronic Presents New Data, Clinical Milestones at CRT 2025

Medtronic presents new data, clinical milestones at CRT 2025.

PR Newswire
Mar 9th, 2025
Smart Trial Two-Year Data Continues To Demonstrate Superior Valve Performance For Evolut Tavr™ System In Small Annulus Patients

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devicesGALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR). In patients with aortic stenosis and a small aortic annulus, results showed comparable composite outcome of mortality, disabling stroke, and heart failure hospitalization, and continued superior valve performance as measured by bioprosthetic valve dysfunction (BVD) at two years for Evolut™ TAVR compared to SAPIEN™. The late-breaking science was presented at the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C."Valve performance is critical for all patients, but the impact of poor valve performance is magnified in patients with a small aortic annulus, who are at risk of receiving a valve that is not adequate for their cardiac requirements," said Howard C. Herrmann, M.D., Perelman School of Medicine at the University of Pennsylvania, and lead investigator of the trial. "The two-year results highlight the continued superior performance of the Evolut TAVR valve in these patients. While we would not yet expect to see a significant difference in the composite clinical outcomes at this early stage, valve performance provides important data that operators can use to inform and personalize treatment decisions to enhance patient outcomes."The SMART two-year data demonstrated that Evolut TAVR continues to show significantly less BVD, which can be a predictor of adverse outcomes1, compared to SAPIEN TAVR